Clinical Trials Browser

Phase 2 × Sarcoma × abemaciclib × Clear all

NCT04040205 2025-07-20

Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

Phase 2 Recruiting

Other solid neoplasmSarcoma

Chondrosarcoma, Retinoblastoma, Sarcoma, Osteosarcoma

NCT02846987 2025-06-05

Study of Abemaciclib in Dedifferentiated Liposarcoma

Phase 2 Active not recruiting

Liposarcoma, Sarcoma